Company intelligence / Profile preview

AusculSciences

Vienna, Virginia, United Statesausculsciences.com ↗

Ownership: Private
Development stage: Commercial

Overview

AusculSciences has developed a non-invasive, touchless stethoscope system ("Auscul-X") that enables clinicians to listen to heart and lung sounds from a safe distance. The technology is designed to improve safety during infectious outbreaks like COVID‑19 by reducing the need for close contact and PPE use. The system was set for clinical evaluation at the University of Ottawa Heart Institute in mid‑2020, with commercial launch targeted soon after. Over $10 million has been raised from investors to develop this technology.

Therapeutic areas: CardiovascularInfectious Diseases
Modalities: DeviceSoftware solution (for clinical decision support)
Industry: Physiological Monitoring

Partnerships

University of Ottawa Heart Institute (clinical study site)

Beyond the preview

Go deeper on AusculSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AusculSciences.

Explore the full profile